Journal
NATURE REVIEWS MICROBIOLOGY
Volume 14, Issue 5, Pages 273-287Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrmicro.2016.17
Keywords
-
Categories
Funding
- US National Institutes of Health [R01AT008618, R01HL122593, F32DK101154]
- Young Investigator Grant for Probiotics Research
- George Williams Hooper Research Foundation
- University of California San Francisco (UCSF) Department of Microbiology Immunology
- Damon Runyon Cancer Research Foundation [DRR-42-16]
Ask authors/readers for more resources
Although the importance of human genetic polymorphisms in therapeutic outcomes is well established, the role of our 'second genome' (the microbiome) has been largely overlooked. In this Review, we highlight recent studies that have shed light on the mechanisms that link the human gut microbiome to the efficacy and toxicity of xenobiotics, including drugs, dietary compounds and environmental toxins. Continued progress in this area could enable more precise tools for predicting patient responses and for the development of a new generation of therapeutics based on, or targeted at, the gut microbiome. Indeed, the admirable goal of precision medicine may require us to first understand the microbial pharmacists within.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available